10:53 IST
BSE
Promoter Selling
Thyrocare Technologies Promoter Selling
Promoter Docon Technologies sold 1,57,69,696 equity shares of Thyrocare Technologies. Promoter shareholding decreased from 60.92% to 51.02%.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
1 announcement with these filters
Promoter Docon Technologies sold 1,57,69,696 equity shares of Thyrocare Technologies. Promoter shareholding decreased from 60.92% to 51.02%.